Prognostic value of neuroendocrine differentiation in adenocarcinoma of prostate in relation to progression of disease after endocrine therapy - Comment

被引：0
|
作者：
DiSantAgnese, PA
机构：
来源：
JOURNAL OF UROLOGY | 1997年 / 158卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：174 / 174
页数：1
相关论文
共 50 条
  • [41] The relation of androgen receptors status, neuroendocrine differentiation and angiogenesis to biochemical failure after radical prostatectomy for localized prostate cancer.
    Revelos, K
    Petraki, CD
    Vaslamatzis, MM
    Papanastassiou, P
    Mastoris, C
    Magkou, C
    Argyrakos, T
    Alevizopoulos, N
    Vrionis, E
    Koutsilieris, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 429S - 429S
  • [42] A review of salvage treatment options for disease progression after radiation therapy for localized prostate cancer
    Steele, Ethan M.
    Holmes, Jordan A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 582 - 598
  • [43] Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy
    S B Stewart
    J C Cheville
    T J Sebo
    I Frank
    S A Boorjian
    R H Thompson
    M T Gettman
    M K Tollefson
    E C Umbriet
    S P Psutka
    E J Bergstralh
    L Rangel
    R J Karnes
    Prostate Cancer and Prostatic Diseases, 2014, 17 : 332 - 337
  • [44] Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy - Editorial comment
    Schmid, HP
    EUROPEAN UROLOGY, 2003, 44 (03) : 314 - 314
  • [45] Can Dutasteride Delay or Prevent the Progression of Prostate Cancer in Patients With Biochemical Failure After Radical Therapy? Rationale and Design of the Avodart After Radical Therapy for Prostate Cancer Study Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2009, 182 (05): : 2311 - 2311
  • [46] Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy
    Freedland, Stephen J.
    Gerber, Leah
    Reid, Julia
    Welbourn, William
    Tikishvili, Eliso
    Park, Jimmy
    Younus, Adib
    Gutin, Alexander
    Sangale, Zaina
    Lanchbury, Jerry S.
    Salama, Joseph K.
    Stone, Steven
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (05): : 848 - 853
  • [47] Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer
    Nonomura, Norio
    Takayama, Hitoshi
    Nakayama, Masashi
    Nakai, Yasutomo
    Kawashima, Atsunari
    Mukai, Masatoshi
    Nagahara, Akira
    Aozasa, Katsuyuki
    Tsujimura, Akira
    BJU INTERNATIONAL, 2011, 107 (12) : 1918 - 1922
  • [48] Erlotinib Salvage Therapy in Pulmonary Adenocarcinoma Patients With Disease Progression After Previous EGFR-TKI Treatment
    Wu, Wen-Shuo
    Wu, Chieh-Hung
    Lai, Shinn-Liang
    Chiu, Chao-Hua
    Shih, Jen-Fu
    Lee, Yu-Chin
    Chen, Yuh-Min
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (06): : 556 - 562
  • [49] Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer
    Dowsett, Mitch
    Smith, Ian E.
    Ebbs, Stephen R.
    Dixon, J. Michael
    Skene, Anthony
    A'Hern, Roger
    Salter, Janine
    Detre, Simone
    Hills, Margaret
    Walsh, Geraldine
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (02): : 167 - 170
  • [50] Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical pro statectomy
    Stewart, S. B.
    Cheville, J. C.
    Sebo, T. J.
    Frank, I.
    Boorjian, S. A.
    Thompson, R. H.
    Gettman, M. T.
    Tollefsonl, M. K.
    Umbriet, E. C.
    Psutka, S. P.
    Bergstralh, E. J.
    Rangel, L.
    Karnes, R. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (04) : 332 - 337
12345